Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Short-Term Debt issuances (2016 - 2022)

Historic Short-Term Debt issuances for Prestige Consumer Healthcare (PBH) over the last 11 years, with Q2 2022 value amounting to $20.0 million.

  • Prestige Consumer Healthcare's Short-Term Debt issuances fell 7647.06% to $20.0 million in Q2 2022 from the same period last year, while for Mar 2023 it was $20.0 million, marking a year-over-year decrease of 7647.06%. This contributed to the annual value of $20.0 million for FY2023, which is 7647.06% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Short-Term Debt issuances stood at $20.0 million for Q2 2022, which was down 7647.06% from $85.0 million recorded in Q2 2021.
  • Over the past 5 years, Prestige Consumer Healthcare's Short-Term Debt issuances peaked at $85.0 million during Q2 2021, and registered a low of $10.0 million during Q1 2018.
  • In the last 5 years, Prestige Consumer Healthcare's Short-Term Debt issuances had a median value of $15.0 million in 2018 and averaged $25.0 million.
  • In the last 5 years, Prestige Consumer Healthcare's Short-Term Debt issuances tumbled by 8888.89% in 2018 and then skyrocketed by 5000.0% in 2019.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Short-Term Debt issuances stood at $15.0 million in 2018, then changed by 0.0% to $15.0 million in 2019, then changed by 0.0% to $15.0 million in 2020, then surged by 466.67% to $85.0 million in 2021, then crashed by 76.47% to $20.0 million in 2022.
  • Its Short-Term Debt issuances stands at $20.0 million for Q2 2022, versus $85.0 million for Q2 2021 and $15.0 million for Q4 2020.